Ubs Group Ag Paratek Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$1.52 - $2.8 $3,027 - $5,577
-1,992 Reduced 19.38%
8,284 $18,000
Q1 2023

May 12, 2023
BUY
$1.37 - $2.54 $13,891 - $25,755
10,140 Added 7455.88%
10,276 $26,000
Q4 2022

Feb 08, 2023
SELL
$1.67 - $2.51 $1,743 - $2,620
-1,044 Reduced 88.47%
136 $0
Q3 2022

Nov 10, 2022
SELL
$1.96 - $2.93 $4,147 - $6,199
-2,116 Reduced 64.2%
1,180 $3,000
Q2 2022

Aug 10, 2022
BUY
$1.73 - $3.09 $1,451 - $2,592
839 Added 34.15%
3,296 $6,000
Q1 2022

May 16, 2022
SELL
$2.94 - $4.77 $40,639 - $65,935
-13,823 Reduced 84.91%
2,457 $7,000
Q4 2021

Feb 14, 2022
BUY
$4.07 - $5.3 $55,673 - $72,498
13,679 Added 525.91%
16,280 $74,000
Q3 2021

Nov 15, 2021
BUY
$4.7 - $7.24 $2,895 - $4,459
616 Added 31.03%
2,601 $12,000
Q2 2021

Aug 13, 2021
SELL
$6.81 - $10.93 $17,324 - $27,805
-2,544 Reduced 56.17%
1,985 $13,000
Q1 2021

May 12, 2021
SELL
$6.14 - $8.31 $18,475 - $25,004
-3,009 Reduced 39.92%
4,529 $32,000
Q4 2020

Feb 11, 2021
BUY
$4.58 - $7.14 $27,796 - $43,332
6,069 Added 413.14%
7,538 $47,000
Q3 2020

Nov 12, 2020
SELL
$4.19 - $6.69 $48,847 - $77,992
-11,658 Reduced 88.81%
1,469 $8,000
Q2 2020

Jul 31, 2020
SELL
$2.97 - $5.22 $18,197 - $31,982
-6,127 Reduced 31.82%
13,127 $69,000
Q1 2020

May 01, 2020
SELL
$2.67 - $4.97 $57,503 - $107,038
-21,537 Reduced 52.8%
19,254 $61,000
Q4 2019

Feb 14, 2020
BUY
$2.93 - $4.5 $61,787 - $94,896
21,088 Added 107.03%
40,791 $164,000
Q3 2019

Nov 14, 2019
BUY
$3.08 - $5.76 $60,685 - $113,489
19,703 New
19,703 $85,000
Q2 2019

Aug 14, 2019
SELL
$3.47 - $6.32 $5,205 - $9,480
-1,500 Closed
0 $0
Q1 2019

May 14, 2019
SELL
$5.36 - $7.24 $8,238 - $11,127
-1,537 Reduced 50.61%
1,500 $8,000
Q4 2018

Feb 14, 2019
BUY
$4.8 - $11.6 $14,577 - $35,229
3,037 New
3,037 $16,000
Q3 2018

Nov 14, 2018
SELL
$9.05 - $10.95 $31,675 - $38,325
-3,500 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$10.2 - $13.9 $15,911 - $21,684
1,560 Added 80.41%
3,500 $36,000
Q1 2018

May 15, 2018
SELL
$12.65 - $18.85 $14,484 - $21,583
-1,145 Reduced 37.12%
1,940 $25,000
Q4 2017

Feb 14, 2018
SELL
$17.45 - $25.6 $27,675 - $40,601
-1,586 Reduced 33.95%
3,085 $56,000
Q3 2017

Nov 14, 2017
SELL
$18.9 - $28.2 $1.07 Million - $1.6 Million
-56,855 Reduced 92.41%
4,671 $117,000
Q2 2017

Aug 14, 2017
BUY
N/A
61,526
61,526 $1.48 Million

Others Institutions Holding PRTK

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Paratek Pharmaceuticals, Inc.

PRTK Quotes by TradingView
  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email